{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T16:55:39Z","timestamp":1772470539543,"version":"3.50.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T00:00:00Z","timestamp":1259020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Plasma cell hepatitis (PCH) is characterized by plasma cell infiltration seen in allografts of patients who underwent liver transplantation (LT) for conditions other than autoimmune hepatitis. We identified 40 PCH patients who underwent LT for hepatitis C virus (HCV) by searching our pathology database (1994-2006) for the keywords\n                      <jats:italic toggle=\"yes\">liver allograft<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">lymphoplasmacytic<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">plasma cell(s<\/jats:italic>\n                      ). We selected 2 control patients who received LT for HCV for each PCH case. The control patients were matched according to date of LT and availability of biopsy material at the time interval to development of PCH in PCH patients. Explant and post-LT biopsy slides were blindly reviewed by 2 liver pathologists and the severity of the plasma cell infiltrate was scored. A score of 3 (plasma cells composing &gt;30% of the infiltrate) defined PCH in allograft biopsies. Five random areas of dense inflammation were also examined in explant livers and the highest score was used. Poor outcome was defined as death or advanced fibrosis (stage \u2265 4 of 6). We found that PCH patients were more likely to have worse outcomes than control patients (65% versus 40%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01), including increased mortality (50% versus 30%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Kaplan-Meier survival analysis showed significantly worse survival for PCH patients from 4 to 10 years post-LT (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Explants from 40% of PCH patients had a score of 3 compared to 18% of control patients (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). We found that the development of PCH is associated with poor outcome in patients undergoing LT for HCV. The association of significant plasma cell infiltrates in native livers of HCV patients developing PCH suggests that some patients may have a predisposition to developing PCH. Liver Transpl 15:1826-1833, 2009. \u00a9 2009 AASLD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/lt.21949","type":"journal-article","created":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T14:48:00Z","timestamp":1259074080000},"page":"1826-1833","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":54,"title":["Plasma Cell Hepatitis in Hepatitis C Virus Patients Post-Liver Transplantation"],"prefix":"10.1097","volume":"15","author":[{"given":"Stephen C.","family":"Ward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swan N.","family":"Thung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel M.","family":"Fiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-22-20260302","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: an international consensus document.","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"R2-22-20260302","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"R3-22-20260302","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis.","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"R4-22-20260302","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis: a need for reassessment.","volume":"13","author":"Scheuer","year":"1991","journal-title":"J Hepatol"},{"key":"R5-22-20260302","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence.","volume":"52","author":"Duclos-Vallee","year":"2003","journal-title":"Gut"},{"key":"R6-22-20260302","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00007890-198404000-00009","article-title":"Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting.","volume":"37","author":"Neuberger","year":"1984","journal-title":"Transplantation"},{"key":"R7-22-20260302","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.transproceed.2007.02.030","article-title":"Liver transplantation for autoimmune hepatitis: a single-center experience.","volume":"39","author":"Khalaf","year":"2007","journal-title":"Transplant Proc"},{"key":"R8-22-20260302","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jlts.2002.32981","article-title":"Incidence and recurrence of autoimmunealloimmune hepatitis in liver transplant recipients.","volume":"8","author":"Molmenti","year":"2002","journal-title":"Liver Transpl"},{"key":"R9-22-20260302","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis.","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"key":"R10-22-20260302","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/hep.21152","article-title":"Progressive histological damage in liver allografts following pediatric liver transplantation.","volume":"43","author":"Evans","year":"2006","journal-title":"Hepatology"},{"key":"R11-22-20260302","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.TP.0000132328.33460.43","article-title":"Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.","volume":"78","author":"Miyagawa-Hayashino","year":"2004","journal-title":"Transplantation"},{"key":"R12-22-20260302","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.510300103","article-title":"Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis.","volume":"30","author":"Jones","year":"1999","journal-title":"Hepatology"},{"key":"R13-22-20260302","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/jlts.2001.23792","article-title":"Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation.","volume":"7","author":"Tan","year":"2001","journal-title":"Liver Transpl"},{"key":"R14-22-20260302","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.humpath.2006.08.028","article-title":"Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients.","volume":"38","author":"Khettry","year":"2007","journal-title":"Hum Pathol"},{"key":"R15-22-20260302","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.26756","article-title":"Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults.","volume":"34","author":"Heneghan","year":"2001","journal-title":"Hepatology"},{"key":"R16-22-20260302","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/lt.21447","article-title":"Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.","volume":"14","author":"Fiel","year":"2008","journal-title":"Liver Transpl"},{"key":"R17-22-20260302","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R18-22-20260302","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/hep.510260229","article-title":"Histological findings in chronic hepatitis C with autoimmune features.","volume":"26","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"R19-22-20260302","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy.","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R20-22-20260302","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaut.2006.09.003","article-title":"The peptide specificities of the autoantibodies elicited by mouse hepatitis virus A59.","volume":"27","author":"Duhalde-Vega","year":"2006","journal-title":"J Autoimmun"},{"key":"R21-22-20260302","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/lt.21518","article-title":"Plasma cell hepatitis in liver allografts: variant of rejection or autoimmune hepatitis?","volume":"14","author":"Demetris","year":"2008","journal-title":"Liver Transpl"},{"key":"R22-22-20260302","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0016-5085(99)70454-3","article-title":"European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.","volume":"117","author":"Feray","year":"1999","journal-title":"Gastroenterology"},{"key":"R23-22-20260302","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/lt.21060","article-title":"Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.","volume":"13","author":"Seyam","year":"2007","journal-title":"Liver Transpl"},{"key":"R24-22-20260302","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/lt.21108","article-title":"Natural history of unexplained chronic hepatitis after liver transplantation.","volume":"13","author":"Syn","year":"2007","journal-title":"Liver Transpl"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.21949","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.21949","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200912000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T16:01:47Z","timestamp":1772467307000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200912000-00022"}},"subtitle":["Case-Control Study Showing Poor Outcome and Predictive Features in the Liver Explant"],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.21949","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}